Ibrahim Abubakar

Last updated
Ibrahim Abubakar

FMedSci FRCP FFPH
Ibrahim Abubakar.jpg
NationalityBritish
Alma mater London School of Hygiene & Tropical Medicine
University of Cambridge
University of East Anglia
Scientific career
Fields Epidemiology and global health
Institutions University College London
University of East Anglia
Thesis An epidemiological investigation of the role of mycobacterium avium subspecies paratuberculosis in the aetiology of Chrohn's disease  (2007)
Website https://iris.ucl.ac.uk/iris/browse/profile?upi=IABUB15

Ibrahim Ibrahim Abubakar FFPH FRCPE FRCP FMedSci is a British-Nigerian epidemiologist who is Professor in Infectious Disease Epidemiology at University College London and Dean of the UCL Faculty of Population Health Sciences. [1] [2] [3]

Contents

Education

He qualified in medicine in 1992 from Ahmadu Bello University and initially trained in general medicine before specialising in public health medicine. [4] He trained in public health at the London School of Hygiene and Tropical Medicine graduating with an MSc in 1999, DPH from the University of Cambridge in 2000 and a PhD from the University of East Anglia in 2007. [5] He was elected to the Fellowship of the Academy of Medical Sciences in 2020 in recognition of his research in infectious disease epidemiology and migration and health. [6]

Work

He was director of the UCL Institute for Global Health until August 2021. [7] He previously served as head of TB at Public Health England. [8] Prior to his appointment at UCL, he was Professor in Health Protection at Norwich Medical School. In 2011, he was awarded a Senior Research Fellowship by the National Institute for Health and Care Research (NIHR) on tuberculosis [9] and in 2016 he was appointed as an NIHR Senior Investigator. [10]

He is the chair of the NIHR Global Professorship Selection Committee [11] and of the Wellcome Trust Population Health Expert Review Group [12] and the Lancet Migration Initiative. [13] He was an Advisory Board member of the Public Health Board of Open Society Foundation [14] and of the MRC Applied Global Health Board. [15] He is also on the Editorial Board of the European Respiratory Journal and BMC Medicine. [16] [17]

He served as the chair of the WHO Strategic and Technical Advisory Group for Tuberculosis (STAG TB) from 2016 to 2019 [18] and co-chaired the NICE TB guidelines development group, [19] and was a board member, Africa Research Excellence Fund. [20]

Research and publications

Abubakar led the Lancet Nigeria Commission [21] which was launched in March 2022 in Abuja with media coverage [22] and has influenced national health policy in Nigeria including the recent passage of the National Health Insurance Authority Act 2022. [23] He led the UCL-Lancet Commission on Migration and Health [24] which dispelled myths regarding the perceived threat from migration to public health and urged action on improved health provision for migrants. The results were especially topical in the context of mass migration in the Mediterranean and in central and North America. The findings of the commission achieved widespread media coverage, such as reports in The Guardian, NBC News, and at the World Economic Forum. [25] [26] [27]

He co-edited the Oxford Specialist Handbook in Infectious Disease Epidemiology published in 2016. [28] His work on mass gathering medicine in 2012 as part of the Lancet infectious Diseases Mass Gathering Medicine Series [29] generated media interest due to the potential impact of pandemics in crowded settings (London 2012: Mass gathering risks disease spreading). [30]

He is widely published in tuberculosis epidemiology, diagnosis and control with media coverage including research on tuberculosis screening, [31] work showing high risk of TB in pregnancy and the postpartum period, tuberculosis and air travel, [32] and on the effects of BCG in TB prevention. [33] He leads the E-DETECT TB project in Europe for the early detection of tuberculosis, [34] which in Romania has led to the expansion of mobile x-ray screening through €15 million investment in similar units to travel around the country. [35]

He has an h-index of 90 according to Google Scholar. [36]

Other activities

Related Research Articles

<span class="mw-page-title-main">Medical Research Council (United Kingdom)</span> National medical research agency

The Medical Research Council (MRC) is responsible for co-coordinating and funding medical research in the United Kingdom. It is part of United Kingdom Research and Innovation (UKRI), which came into operation 1 April 2018, and brings together the UK's seven research councils, Innovate UK and Research England. UK Research and Innovation is answerable to, although politically independent from, the Department for Business, Energy and Industrial Strategy.

Professor John Grange died 10 October 2016 was an English immunologist, epidemiologist, researcher, and academic, and was one of Europe's leading tuberculosis specialists.

<span class="mw-page-title-main">Mario Raviglione</span>

Mario C. Raviglione has been professor at the University of Milan, Italy since March 2018. He directs the activities focused on global health and aiming at pursuing didactic and research in this field as part of the new Multidisciplinary Research in Health Science (MACH) Centre. Part of his activities are devoted to teaching global health principles to undergraduate medical students, making the University of Milan the first in Italy, and one of the pioneers world-wide, introducing global health as a module among the required courses. At the same university, Raviglione is now coordinating the establishment of the first international online Master Course in Global Health in Italy . In 2019 and 2020, he was also Professeur Titulaire at the Global Studies Institute (GSI), Université de Genève, Suisse. Through the GSI, he has worked within the context of the Institute of Global Health. Previously, between 2003 and 2017, he was director of the Global Tuberculosis Programme at the World Health Organization (WHO) . He graduated in medicine from the University of Turin in 1980 and then trained in internal medicine and Infectious Diseases at Cabrini Medical Center in New York City and at Beth Israel Medical Center in Boston where he was a Harvard University Clinical Fellow in Medicine and specialised in AIDS. Back in Europe, Raviglione joined WHO in 1991 as a Junior Professional Officer, and spent a few years working on TB and AIDS, TB epidemiology in Europe, and anti-TB drug resistance surveillance and response. In the mid-1990s, he set up both the WHO global drug resistance surveillance project and the WHO global TB surveillance and monitoring systems. Among his major achievements are the contributions to the development of the WHO's DOTS Strategy in 1995, and the direction of the development of both the Stop TB Strategy in 2006 and the End TB Strategy in 2014. During his years at WHO he worked with, and visited, more than 50 countries supporting their TB care, prevention, control and research activities. His research work has resulted in over 350 scientific articles and chapters on the topics of infectious diseases, HIV/AIDS, TB, and global health, including the TB chapters in the last eight editions of Harrison's Principles of Internal Medicine. He is editor of the 3rd and 4th edition of "Tuberculosis - A comprehensive international approach", a multi-author book, and associate editor of other books on public health, infectious diseases and tuberculosis. He directed the team that developed the book “Systematic screening for active tuberculosis – Principles and recommendations”, awarded by the British Medical Association as "Highly Commended Book" for Public Health in 2014. He is among the top 10 most cited authors in the TB field. His h-index is 107 and 87 (Scinapse) and his work has been cited over 55000 times. He is also among the top 25 Italian epidemiological scientists and the top 100 Italian scientists in general. As an expert in TB, he has worked as a teacher or visiting professor at Johns Hopkins University, University of Geneva, University of Modena and Reggio Emilia, and University of Pavia. He has been visiting professor at the University of Brescia and has recently lectured at major universities including Harvard, McGill and Sydney. He participates in a variety of board of directors, scientific and advisory committees, including those of the TB Alliance, Doctors with Africa CUAMM, BE Health Association, International Health Commission of the Missionary Sisters of the Sacred Heart - Cabrini Ministries ,Fondazione 3Bi. and the McGill Global Health Programs International Advisory Board. In 2017-2018 he was member of the Lancet Commission on TB. During 2015-2017 he conceived and co-organised, with WHO and the Russian Federation Ministry of Health, the first Global WHO Ministerial Conference on TB in the Sustainable Development Era, held in Moscow on 16-17 November 2017, and his team worked towards ensuring that TB is raised in the international political agenda through the United Nations General Assembly high-level meeting on TB that was held in 2018.

<span class="mw-page-title-main">Alimuddin Zumla</span> British-Zambian physician

Sir Alimuddin Zumla,, FRCP, FRCPath, FRSB is a British-Zambian professor of infectious diseases and international health at University College London Medical School. He specialises in infectious and tropical diseases, clinical immunology, and internal medicine, with a special interest in HIV/AIDS, respiratory infections, and diseases of poverty. He is known for his leadership of infectious/tropical diseases research and capacity development activities. He was awarded a Knighthood in the 2017 Queens Birthday Honours list for services to public health and protection from infectious disease. In 2012, he was awarded Zambia's highest civilian honour, the Order of the Grand Commander of Distinguished services - First Division. In 2022, for the fifth consecutive year, Zumla was recognised by Clarivate Analytics, Web of Science as one of the world's top 1% most cited researchers. In 2021 Sir Zumla was elected as Fellow of The World Academy of Sciences.

<span class="mw-page-title-main">Andrew Hayward</span> University academic into infectious disease epidemiology

Andrew C Hayward MBBS, BSc, MSc, DTMH, MD, FPHM, is professor of infectious disease epidemiology and inclusion health research at University College London.

Dame Anne Mandall Johnson DBE FMedSci is a British epidemiologist, known for her work in public health, especially the areas of HIV, sexually transmitted infections and infectious diseases.

<span class="mw-page-title-main">Soumya Swaminathan</span> Indian and WHO Deputy Director general

Soumya Swaminathan is an Indian paediatrician and clinical scientist known for her research on tuberculosis and HIV. From 2019 to 2022, she served as the chief scientist at the World Health Organization under the leadership of Director General Tedros Adhanom Ghebreyesus. Previously, from October 2017 to March 2019, she was the Deputy Director General of Programmes (DDP) at the World Health Organization.

Ramani Moonesinghe OBE MD(Res) FRCP FRCA FFICM SFFMLM is Professor of Perioperative Medicine at University College London (UCL) and a Consultant in Anaesthetics and Critical Care Medicine at UCL Hospitals. Moonesinghe was Director of the National Institute for Academic Anaesthesia (NIAA) Health Services Research Centre between 2016 and 2022, and between 2016 and 2019 was Associate National Clinical Director for Elective Care for NHS England. In 2020 on she took on the role of National Clinical Director for Critical and Perioperative care at NHS England and NHS Improvement.

Sharon Jayne Peacock is a British microbiologist who is Professor of Public Health and Microbiology in the Department of Medicine at the University of Cambridge.

<span class="mw-page-title-main">Jonathan Friedland</span> British physician and medical researcher

Professor Jonathan Samuel Friedland is a British physician and medical researcher who is Deputy Vice-Chancellor and Professor of Infectious Diseases at St George's, University of London.

<span class="mw-page-title-main">Tolullah Oni</span> Nigerian urban epidemiologist

Tolullah "Tolu" Oni is a Nigerian urban epidemiologist at the Medical Research Council Epidemiology Unit at the University of Cambridge. She is a NextEinstein Forum Fellow and World Economic Forum Young Global Leader.

<span class="mw-page-title-main">Helen McShane</span> British virologist

Helen Irene McShane is a British infectious disease physician and a professor of vaccinology, in the Jenner Institute at the University of Oxford, where she has led the tuberculosis vaccine research group since 2001. She is senior research fellow at Harris Manchester College, Oxford.

<span class="mw-page-title-main">Chikwe Ihekweazu</span> Nigerian epidemiologist

Chikwe Ihekweazu is a Nigerian epidemiologist, public health physician and World Health Organization’s Assistant Director-General for Health Emergency Intelligence.

Rosalind Raine is a British applied health research scientist, public medicine doctor, professor of health care evaluation and the founding head of the Department of Applied Health Research at University College London (UCL).

Elizabeth Lucy Corbett is a British epidemiologist who is Professor of Tropical Epidemiology at the London School of Hygiene & Tropical Medicine. Her research investigates the regulation of tuberculosis in HIV prevalent populations and improving access to HIV self-testing.

Alison Helen Holmes is a British infectious diseases specialist, who is a professor at Imperial College London. Holmes serves as Director of the National Institute for Health Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance and Consultant at Hammersmith Hospital. Holmes is on the Executive Committee of the International Society of Infectious Diseases, and she serves on a variety of World Health Organization (WHO) expert groups related to antimicrobial use, Antimicrobial Resistance (AMR), infection prevention and sepsis. Her research considers how to mitigate antimicrobial resistance.

Russell Mardon Viner, FMedSci is an Australian-British paediatrician, data scientist, policy researcher and Professor of Adolescent Health at the UCL Great Ormond Street Institute of Child Health. He is an expert on child and adolescent health in the UK and internationally. He was a member of the UK Government's Scientific Advisory Group for Emergencies (SAGE) during the COVID-19 pandemic and was President of the Royal College of Paediatrics and Child Health from 2018 to 2021. He remains clinically active, seeing young people with diabetes each week at UCL Hospitals. His research focuses on the health of children and young people, from global analyses of social determinants of health and global burden of disease (GBD), through use of ‘big’ routine data in children and young people’s healthcare, to conducting intervention studies both at the school level and clinical interventions in obesity and diabetes.

Megan Blanche Murray is an American epidemiologist and an infectious disease physician. She is the Ronda Stryker and William Johnston Professor of Global Health in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health.

Madhukar Pai is a medical doctor, academic, advocate, writer, and university professor. Pai's work is around global health, specifically advocacy for better treatment for tuberculosis with a focus on South Africa and India. Pai is the Canada Research Chair of Epidemiology and Global Health at McGill University.

Ifedayo Morayo Adetifa, a Nigerian paediatrician and infectious diseases epidemiologist, is the current Director General of the Nigeria Centre for Disease Control (NCDC). He was appointed to this role in September 2021 by President Muhammadu Buhari to replace Dr. Chikwe Ihekweazu who was the head of the agency since August 2016.

References

  1. ↑ UCL (22 June 2018). "Professor Ibrahim Abubakar". UCL-TB. Retrieved 16 July 2020.{{cite web}}: CS1 maint: url-status (link)
  2. ↑ "Ibrahim-Abubakar-appointed-as-dean". ucl.ac.uk. 12 May 2021. Retrieved 2022-08-12.
  3. ↑ "Iris View Profile". iris.ucl.ac.uk. Retrieved 2020-09-09.
  4. ↑ "Iris View Profile". iris.ucl.ac.uk. Retrieved 2020-09-09.
  5. ↑ "Iris View Profile". iris.ucl.ac.uk. Retrieved 2020-09-09.
  6. ↑ "50 leading biomedical and health scientists elected to the prestigious Academy Fellowship | The Academy of Medical Sciences". acmedsci.ac.uk. Retrieved 2020-09-09.
  7. ↑ "Ibrahim-Abubakar-appointed-as-dean". ucl.ac.uk. 12 May 2021. Retrieved 2022-08-12.
  8. ↑ "Ibrahim Abubakar - Public health matters". publichealthmatters.blog.gov.uk. Retrieved 2020-09-09.
  9. ↑ "NIHR Funding and Awards Search Website". www.dev.fundingawards.nihr.ac.uk. Retrieved 2020-09-09.
  10. ↑ "NIHR Annual Report" (PDF). National Institute for Health Research. Retrieved 2020-09-09.{{cite web}}: CS1 maint: url-status (link)
  11. ↑ "NIHR Research Professorships". nihr.ac.uk. Retrieved 2022-08-12.
  12. ↑ "Population and Public Health Expert Review Group - Grant Funding | Wellcome". wellcome.ac.uk. Retrieved 2020-09-09.
  13. ↑ "OUR TEAM". migrationandhealth. Retrieved 2020-09-09.
  14. ↑ "Public Health Program, Global Health Advisory Committee". www.opensocietyfoundations.org. Retrieved 2020-09-09.
  15. ↑ "Medical Research Council Applied Global Health Board". mrc.ukri.org. 2022-03-31. Retrieved 2022-08-12.
  16. ↑ "Editorial Board | European Respiratory Society". erj.ersjournals.com. Retrieved 2020-09-09.
  17. ↑ "BMC Medicine". BMC Medicine. Retrieved 2020-09-09.
  18. ↑ "Strategic and technical advisory group for tuberculosis" (PDF). World Health Organisation. Retrieved 2020-09-09.{{cite web}}: CS1 maint: url-status (link)
  19. ↑ Hoppe, Lucy Elizabeth; Kettle, Rachel; Eisenhut, Michael; Abubakar, Ibrahim (2016-01-13). "Tuberculosis—diagnosis, management, prevention, and control: summary of updated NICE guidance". BMJ. 352: h6747. doi:10.1136/bmj.h6747. ISSN   1756-1833. PMID   26762607. S2CID   206908943.
  20. ↑ "Our Board's biographies • Africa Research Excellence fund". Africa Research Excellence fund. Retrieved 2020-09-09.
  21. ↑ "Lancet Nigeria Commission". lancet.com. Retrieved 2022-08-12.
  22. ↑ "Nigeria Health System Requires Radical Overhaul". Financial Times. 16 March 2022. Retrieved 2022-08-12.
  23. ↑ "83 million poor nigerians to benefit from new health insurance". vanguardngr.com. Retrieved 2022-08-12.
  24. ↑ "The UCL–Lancet Commission on Migration and Health: the health of a world on the move". www.thelancet.com. Retrieved 2020-09-09.
  25. ↑ "Myths about migrants spreading disease 'inform hostile policies'". the Guardian. 2018-12-05. Retrieved 2020-09-09.
  26. ↑ "Migrants don't bring disease. In fact, they help fight it, report says". NBC News. Retrieved 2020-09-09.
  27. ↑ "Migrants are 'healthier and live longer' than residents in their host countries". World Economic Forum. Retrieved 2020-09-09.
  28. ↑ Abubakar, Ibrahim; Stagg, Helen R.; Cohen, Ted; Rodrigues, Laura C., eds. (2016-04-07). Infectious Disease Epidemiology. Oxford, New York: Oxford University Press. ISBN   978-0-19-871983-0.
  29. ↑ "Mass Gatherings Health". www.thelancet.com. Retrieved 2020-09-09.
  30. ↑ "London 2012 'disease spread risk'". BBC News. 2012-01-16. Retrieved 2020-09-09.
  31. ↑ "Despite progress, tuberculosis persists in West European cities". Reuters. 2014-03-07. Retrieved 2020-09-09.
  32. ↑ "Rules for flying with tuberculosis disputed". The Washington Times. Retrieved 2020-09-09.
  33. ↑ "BCG vaccine prevents TB infection in children". GOV.UK. Retrieved 2020-09-09.
  34. ↑ Abubakar, Ibrahim; Matteelli, Alberto; Vries, Gerard de; Zenner, Dominik; Cirillo, Daniela M.; Lönnroth, Knut; Popescu, Gilda; Barcellini, Lucia; Story, Alistair; Migliori, Giovanni Battista (2018-05-01). "Towards tackling tuberculosis in vulnerable groups in the European Union: the E-DETECT TB consortium". European Respiratory Journal. 51 (5). doi: 10.1183/13993003.02604-2017 . ISSN   0903-1936. PMID   29748241.
  35. ↑ ucltb (2019-10-29). "E-DETECT presented at Romanian Parliament". E-DETECT TB. Retrieved 2020-09-09.
  36. ↑ "Ibrahim Abubakar". Google Scholar . Retrieved 10 February 2023.
  37. ↑ Strategy Group on Health Africa Europe Foundation (AEF).
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.